147 related articles for article (PubMed ID: 38588692)
1. Liver cancer surveillance in people with hepatitis B in Africa.
Ndububa DA
Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):491-492. PubMed ID: 38588692
[No Abstract] [Full Text] [Related]
2. Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page?
Sonneveld MJ; Brouwer WP; de Man RA
J Hepatol; 2020 Sep; 73(3):728-729. PubMed ID: 32423630
[No Abstract] [Full Text] [Related]
3. Reply to: "Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page".
Chan HL; Wong VW; Yip TC; Wong GL
J Hepatol; 2020 Sep; 73(3):729-730. PubMed ID: 32423634
[No Abstract] [Full Text] [Related]
4. Development of hepatocellular carcinoma in chronic viral B and viral C liver diseases.
Acalovschi M
Rom J Gastroenterol; 2003 Jun; 12(2):123-30. PubMed ID: 12853999
[No Abstract] [Full Text] [Related]
5. Hepatocellular carcinoma in sub-Saharan (tropical) Africa.
Balint GA; Ghebrekidan H; Balint E
Acta Med Hung; 1991; 48(3-4):177-87. PubMed ID: 1668371
[TBL] [Abstract][Full Text] [Related]
6. Letter to the editor: Hepatitis B virus genotype: A significant risk factor in determining which patients with chronic hepatitis B virus infection should undergo surveillance for hepatocellular carcinoma: The hepatitis B Alaska study.
Kumar A; Rajani D; Kumar S
Hepatology; 2022 Sep; 76(3):E63-E64. PubMed ID: 35478185
[No Abstract] [Full Text] [Related]
7. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
Basyigit S; Sapmaz F
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1230. PubMed ID: 26327502
[No Abstract] [Full Text] [Related]
8. Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort study.
Ramírez Mena A; Thiam M; Ka D; Niang I; Tine J; Fortes L; Ndiaye K; Ndiaye O; Fall M; Gaye A; Ngom NF; Fall F; Berzigotti A; Kirk GD; Jaquet A; Seydi M; Wandeler G;
Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):539-549. PubMed ID: 38588691
[TBL] [Abstract][Full Text] [Related]
9. [Screening and surveillance for hepatocellular carcinoma in patients with chronic hepatitis B virus infection].
Expert Group for Project of Hepatocellular Carcinoma Screening and Surveillance, Chinese Foundation for Hepatitis Prevention and Control
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):932-941. PubMed ID: 34814387
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus-induced hepatocarcinogenesis: A virological and oncological perspective.
Arslan F; Franci G; Maria Nastri B; Pagliano P
J Viral Hepat; 2021 Aug; 28(8):1104-1109. PubMed ID: 34003561
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification in chronic hepatitis B patients for hepatocellular carcinoma surveillance: management in migrant sub-Saharan African populations.
Cargill Z; Brown SE; Dusheiko G; Agarwal K
Gut; 2021 Mar; 70(3):629-630. PubMed ID: 32606207
[No Abstract] [Full Text] [Related]
12. Surveillance for hepatocellular carcinoma in people of African ancestry with HIV and Hepatitis B.
Patel N; Post FA
Int J STD AIDS; 2022 Feb; 33(2):202-204. PubMed ID: 34546112
[TBL] [Abstract][Full Text] [Related]
13. Current impact of viral hepatitis on liver cancer development: The challenge remains.
de Mattos ÂZ; Debes JD; Boonstra A; Yang JD; Balderramo DC; Sartori GDP; de Mattos AA
World J Gastroenterol; 2021 Jun; 27(24):3556-3567. PubMed ID: 34239269
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and surveillance for hepatocellular carcinoma: New trends.
Singal AG; Lampertico P; Nahon P
J Hepatol; 2020 Feb; 72(2):250-261. PubMed ID: 31954490
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Liver Fibrosis and Cancer in Africa: The PROLIFICA project--a collaborative study of hepatitis B-related liver disease in West Africa.
Howell J; Ladep NG; Lemoine M; Nayagam S; Toure PS; Diop MM; Daveiga Joao Armindo ; Sall AS; Lo G; Crossey MM; Thursz MR; Taylor-Robinson SD; Ka MM
S Afr Med J; 2015 Mar; 105(3):185-6. PubMed ID: 26294822
[No Abstract] [Full Text] [Related]
16. Incidence of Malignancies Among Patients With Chronic Hepatitis B in US Health Care Organizations, 2006-2018.
Spradling PR; Xing J; Zhong Y; Rupp LB; Moorman AC; Lu M; Teshale EH; Schmidt MA; Daida YG; Boscarino JA; Gordon SC
J Infect Dis; 2022 Sep; 226(5):896-900. PubMed ID: 35039863
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular Carcinoma Occurs at an Earlier Age in Africans, Particularly in Association With Chronic Hepatitis B.
Yang JD; Gyedu A; Afihene MY; Duduyemi BM; Micah E; Kingham TP; Nyirenda M; Nkansah AA; Bandoh S; Duguru MJ; Okeke EN; Kouakou-Lohoues MJ; Abdo A; Awuku YA; Ajayi AO; Omonisi AE; Ocama P; Malu AO; Mustapha S; Okonkwo U; Kooffreh-Ada M; Debes JD; Onyekwere C; Ekere F; Rufina I; Roberts LR;
Am J Gastroenterol; 2015 Nov; 110(11):1629-31. PubMed ID: 26618430
[No Abstract] [Full Text] [Related]
18. Controversies in the Management of Hepatitis B: Hepatocellular Carcinoma.
Roberts SK; Majeed A; Kemp W
Clin Liver Dis; 2021 Nov; 25(4):785-803. PubMed ID: 34593153
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma.
Gnyawali B; Pusateri A; Nickerson A; Jalil S; Mumtaz K
World J Gastroenterol; 2022 Aug; 28(29):3793-3802. PubMed ID: 36157533
[TBL] [Abstract][Full Text] [Related]
20. Screening for hepatocellular carcinoma in hepatitis B and C chronic carriers in Iran.
Fani A; Fani I; Eshratie B; Samadian P; Fani P; Gorishi Y
Indian J Gastroenterol; 2007; 26(6):297-8. PubMed ID: 18431018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
